Influencing factors on morbidity and mortality in intertrochanteric fractures

[1]  Jenna L. Wilson,et al.  Preoperative Comorbidities Associated With Early Mortality in Hip Fracture Patients: A Multicenter Study , 2023, The Journal of the American Academy of Orthopaedic Surgeons.

[2]  A. Ekin,et al.  Analysis of risk factors affecting mortality in elderly patients operated on for hip fractures: A retrospective comparative study. , 2021, Acta orthopaedica et traumatologica turcica.

[3]  E. Demirel,et al.  Predictive Value of Blood Parameters and Comorbidities on Three-Month Mortality in Elderly Patients With Hip Fracture , 2021, Cureus.

[4]  F. Bagheri,et al.  Comparison of the Dynamic Hip Screw with the Dynamic Hip External Fixator for Intertrochanteric Fractures: Report of a Randomized Controlled Trial. , 2021, The archives of bone and joint surgery.

[5]  Xiping Xu,et al.  Neutrophil counts and the risk of first stroke in general hypertensive adults , 2021, Hypertension Research.

[6]  P. Page,et al.  Inter- and intra-observer reliability of the new AO/OTA classification of proximal femur fractures. , 2020, Injury.

[7]  E. Schemitsch,et al.  Anemia at Presentation Predicts Acute Mortality and Need for Readmission Following Geriatric Hip Fracture , 2020, JB & JS open access.

[8]  D. van der Velde,et al.  Does preoperative hemodynamic preconditioning improve morbidity and mortality after traumatic hip fracture in geriatric patients? A retrospective cohort study , 2020, Archives of Orthopaedic and Trauma Surgery.

[9]  Y. Ha,et al.  Blood Transfusion for Elderly Patients with Hip Fracture: a Nationwide Cohort Study , 2020, Journal of Korean medical science.

[10]  P. Banerjee,et al.  Iatrogenic Decompensated Heart Failure , 2020, Current Heart Failure Reports.

[11]  V. Kain,et al.  Role of Neutrophils in Ischemic Heart Failure. , 2020, Pharmacology & therapeutics.

[12]  Guilherme Boni,et al.  Does Early Surgical Fixation of Proximal Femoral Fractures in Elderly Patients Affect Mortality Rates? * , 2019, Revista Brasileira de Ortopedia.

[13]  G. Delhougne,et al.  Incidence and Economic Burden of Intertrochanteric Fracture , 2019, JB & JS open access.

[14]  Young-Kyun Lee,et al.  Difference in Mortality Rate by Type of Anticoagulant in Elderly Patients with Cardiovascular Disease after Hip Fractures , 2019, Clinics in orthopedic surgery.

[15]  T. Howe,et al.  Charlson Comorbidity Index Predicts 5-Year Survivorship of Surgically Treated Hip Fracture Patients , 2018, Geriatric orthopaedic surgery & rehabilitation.

[16]  D. Hermann,et al.  Implications of polymorphonuclear neutrophils for ischemic stroke and intracerebral hemorrhage: Predictive value, pathophysiological consequences and utility as therapeutic target , 2018, Journal of Neuroimmunology.

[17]  Y. Yuh,et al.  A Paradigm Shift: Perioperative Iron and Erythropoietin Therapy for Patient Blood Management , 2018 .

[18]  P. Homel,et al.  The Role of BMI in Hip Fracture Surgery , 2018, Geriatric orthopaedic surgery & rehabilitation.

[19]  M. Reed,et al.  Dose optimisation of intravenous tranexamic acid for elective hip and knee arthroplasty , 2017, Bone & joint research.

[20]  S. A. M. Nasab,et al.  The assessment of mortality and quality of life after intertrochanteric fracture of femur in patients older than 60 at Emam Khomeini Hospital of Ahvaz , 2017, Pakistan journal of medical sciences.

[21]  B. Erickson,et al.  In-hospital mortality risk of intertrochanteric hip fractures: a comprehensive review of the US Medicare database from 2005 to 2010 , 2017, MUSCULOSKELETAL SURGERY.

[22]  Jun Lu,et al.  Laboratory nutritional parameters predict one-year mortality in elderly patients with intertrochanteric fracture. , 2016, Asia Pacific journal of clinical nutrition.

[23]  A. Dahan,et al.  Erythropoietin to reduce allogeneic red blood cell transfusion in patients undergoing total hip or knee arthroplasty , 2016, Vox Sanguinis.

[24]  Yunus Guzel,et al.  Topical Tranexamic Acid versus Autotransfusion after Total Knee Arthroplasty , 2016, Journal of orthopaedic surgery.

[25]  I. Moppett,et al.  A systematic review of pre‐operative anaemia and blood transfusion in patients with fractured hips , 2015, Anaesthesia.

[26]  P. Tong,et al.  Intertrochanteric hip fracture surgery in Chinese: risk factors for predicting mortality. , 2015, International journal of clinical and experimental medicine.

[27]  I. Mohamed,et al.  A systematic review of the outcomes of osteoporotic fracture patients after hospital discharge: morbidity, subsequent fractures, and mortality , 2014, Therapeutics and clinical risk management.

[28]  J. Torres,et al.  Impact of preoperative analytical values on post-operative mortality rate of intertrochanteric fractures. , 2014, Acta medica portuguesa.

[29]  L. Hooper,et al.  Water-loss dehydration and aging , 2014, Mechanisms of Ageing and Development.

[30]  J. Bader,et al.  Risk factors for complications and in-hospital mortality following hip fractures: a study using the National Trauma Data Bank , 2014, Archives of Orthopaedic and Trauma Surgery.

[31]  Mohit Bhandari,et al.  Similar mortality rates in hip fracture patients over the past 31 years , 2014, Acta orthopaedica.

[32]  R. Hahn,et al.  Preoperative urine-specific gravity and the incidence of complications after hip fracture surgery: A prospective, observational study , 2014, European journal of anaesthesiology.

[33]  Jian-xiong Ma,et al.  The percutaneous compression plate versus the dynamic hip screw for treatment of intertrochanteric hip fractures: a systematic review and meta-analysis of comparative studies. , 2012, Orthopaedics & traumatology, surgery & research : OTSR.

[34]  R. Maheshwari,et al.  Factors Influencing Mortality in Patients on Antiplatelet Agents Presenting with Proximal Femoral Fractures , 2011, Journal of orthopaedic surgery.

[35]  David F.M. Brown,et al.  Association of leukocyte and neutrophil counts with infarct size, left ventricular function and outcomes after percutaneous coronary intervention for ST-elevation myocardial infarction. , 2009, The American journal of cardiology.

[36]  L. Gunningberg,et al.  Hip fracture and pressure ulcers – the Pan‐European Pressure Ulcer Study – intrinsic and extrinsic risk factors * , 2008, International wound journal.

[37]  N. Salamon,et al.  Early Neutrophilia Is Associated With Volume of Ischemic Tissue in Acute Stroke , 2008, Stroke.

[38]  J. Harty,et al.  Anti-Platelet Agents and Surgical Delay in Elderly Patients with Hip Fractures , 2007, Journal of orthopaedic surgery.

[39]  Susan H Case.  In Hospital , 2006 .

[40]  C. Moran,et al.  Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study , 2005, BMJ : British Medical Journal.

[41]  J. Minei,et al.  Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. , 2002, The Journal of trauma.

[42]  D. Triulzi,et al.  Transfusion-induced immunomodulation and its clinical consequences. , 1990, Transfusion medicine reviews.

[43]  A. Güemes,et al.  Autologous blood transfusion as an immunomodulator in experimental sepsis. , 2000, International journal of surgical investigation.

[44]  O. Johnell,et al.  World-wide Projections for Hip Fracture , 1997, Osteoporosis International.

[45]  W. Youden,et al.  Index for rating diagnostic tests , 1950, Cancer.